期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 379, 期 11, 页码 1042-1049出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa1800024
关键词
-
资金
- Breast Cancer Research Foundation
- National Institutes of Health [R35CA197458]
- Israel Science Foundation [1788/15, 1353/12]
- Israel Science Foundation
- NATIONAL CANCER INSTITUTE [R35CA197458] Funding Source: NIH RePORTER
The causes of ovarian dysgenesis remain incompletely understood. Two sisters with XX ovarian dysgenesis carried compound heterozygous truncating mutations in the BRCA2 gene that led to reduced BRCA2 protein levels and an impaired response to DNA damage, which resulted in chromosomal breakage and the failure of RAD51 to be recruited to double-stranded DNA breaks. The sisters also had microcephaly, and one sister was in long-term remission from leukemia, which had been diagnosed when she was 5 years old. Drosophila mutants that were null for an orthologue of BRCA2 were sterile, and gonadal dysgenesis was present in both sexes. These results revealed a new role for BRCA2 and highlight the importance to ovarian development of genes that are critical for recombination during meiosis. (Funded by the Israel Science Foundation and others.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据